Celcuity's Unattributed VC Round

Celcuity raised a round of funding on December 18, 2015. Investors include Brightstone Venture Capital.

Celcuity is developing diagnostic tests that use a patient's live tumor cells to identify the specific biological driver of their cancer. The company's CELx Signaling Function technology represents a …

Articles about Celcuity's Unattributed VC Round: